About: Jason S. Lewis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jason S. Lewis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

cancer researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) 연구원 (ko) 研究者 (ja) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq) cancer researcher (en)
rdfs:label	Jason S. Lewis (en) Jason S. Lewis (es) Jason S. Lewis (nl) Jason S. Lewis (sl) Jason S. Lewis (ast) جايسون إس. لويس (ar) জেসন এস লুইস (bn)
skos:prefLabel	Jason S. Lewis (en) Jason S. Lewis (es) Jason S. Lewis (nl) Jason S. Lewis (sl) Jason S. Lewis (ast) جايسون إس. لويس (ar) জেসন এস লুইস (bn)
name	Jason S. Lewis (en) Jason S. Lewis (es) Jason S. Lewis (nl) Jason S. Lewis (sl) Jason S. Lewis (ast) جايسون إس. لويس (ar) জেসন এস লুইস (bn)
Scopus author ID	wds:Q41485356-50DE448D-BCA9-4E23-AB37-DF01DC191982
Scopus author ID	26643450800
given name	wds:Q41485356-38548E1C-2CE2-4D6E-8247-FD62A4043630
given name	Jason
instance of	wds:Q41485356-5BBE26F7-E621-4CE8-B21B-8E932F332268
instance of	Homo sapiens
award received	wds:Q41485356-8c771651-488b-42b5-b78a-bcf7fde08ff5
award received	Fellow of the American Association for the Advancement of Science
skos:altLabel	Jason Lewis (en)
occupation	wds:Q41485356-0DC3F397-330D-4D15-B21A-737BAF3DA180
employer	wds:Q41485356-3723a79d-4c4c-4274-e2d4-dda012a6462f wds:Q41485356-e07a8069-455c-0837-ad4b-1e9bd7ebfa03
sex or gender	wds:Q41485356-43216298-5916-4E5C-92E9-16DBD46ADCFB
family name	wds:Q41485356-A3D8C353-834F-4F03-8903-9D53CF5FBF0B
occupation	researcher
employer	Memorial Sloan Kettering Cancer Center Weill Cornell Medicine
sex or gender	male
family name	Lewis
ORCID iD	wds:Q41485356-68F95B28-A1BE-4A24-BD57-689DC12F5C43
ORCID iD	https://orcid.org/0000-0001-7065-4534
ORCID iD	0000-0001-7065-4534
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q41485356
is author of	Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake Small animal imaging. current technology and perspectives for oncological imaging Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Preparation of high specific activity (86)Y using a small biomedical cyclotron Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro PET imaging with ⁸⁹Zr: from radiochemistry to the clinic A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Standardized methods for the production of high specific-activity zirconium-89. Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides. Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review Advanced LIGO Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model. Cerenkov luminescence imaging of medical isotopes Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). High purity production and potential applications of copper-60 and copper-61 In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14). DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Imaging tumor burden in the brain with 89Zr-transferrin Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software